No more compromises.

No more compromises.

Nextrast is developing new classes of CT contrast agents that simplify imaging and significantly reduce technical and interpretive errors. These agents enable detailed high-quality scans even in traditionally challenging patient scenarios.

Nextrast is developing new classes of CT contrast agents that simplify imaging and significantly reduce technical and interpretive errors. These agents enable detailed high-quality scans even in traditionally challenging patient scenarios.

Clinical Proof of Concept

Nextrast NX9

Dark Oral Contrast Agent

Nextrast NX9

Dark Oral Contrast Agent

Darkens the bowel lumen evenly, making vascularized tissues and tumors pop.

KEY BENEFITS

➜ Superior Anatomic Delineation
➜ Reduced Radiation Dose
➜ Improved Signal/Noise for AI

APPLICATIONS

  • Oncology

  • Inflammatory Bowel Disease

  • MR Enterography

Clearly distinguishable anatomy

Conventional Positive

Oral Contrast

Similar shades of grey

IND Ready

Nextrast NX10

Novel Intravascular Agent

Nextrast NX10

Novel Intravascular Agent

A non-iodine 'blood-pool' agent that remains bright in the vasculature and organs for minutes, eliminating mis-timed scans. NX10 reveals fine vascular detail and small tumors that are missed with iodinated contrast.

KEY BENEFITS

➜ Extended Imaging Window
➜ Eliminates Mixing Artifacts
➜ Effective Regardless of BMI

APPLICATIONS

  • Cardiovascular Disease

  • Small tumor detection

  • Trauma imaging

Vivid, prolonged, full-vascular enhancement

Non-Contrast

Non-
Contrast

6 sec

6s

40 sec

40s

75 sec

75s

136 sec

136s

240 sec

240s

Conventional Iodine
Poor and inconsistent opacification with rapid washout

Benjamin Yeh, MD

Founder

Brian Miller

CEO

Laura King

Board Member

The Leadership Team

With over 40 years experience, our team is focused on developing the next generation of medical imaging.

With over 40 years experience, our team is focused on developing the next generation of medical imaging.

All information proprietary & confidential

Nextrast Inc ©2026